Enjoy complimentary customisation on priority with our Enterprise License!
Below are some of the key findings from the rheumatology therapeutics market research report
See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.
Get a FREE sample now!
The global rheumatology therapeutics market is expected to grow during the forecast period owing to the increasing prevalence of rheumatic disorders. Rheumatology therapy is proven to have higher efficacy than the other therapies that are currently available in the healthcare industry for the treatment of rheumatoid arthritis. The growth of the global rheumatology therapeutics is expected to be boosted by increased approval of drugs in the development pipeline for the treatment of rheumatic diseases. The rising number of small molecules in the drug development pipeline is one of the major trends being witnessed in the global rheumatology therapeutics. Small molecules are generally less expensive than the biologics and are likely to emerge soon. They will be affordable on a large scale by the patients with juvenile rheumatoid arthritis, axial spondylitis and ankylosing spondylitis, which will drive the market growth. The global rheumatology therapeutics market to grow at a CAGR of over 4% by 2022.
The rheumatology therapeutics market is fairly fragmented. Most of the established rheumatology therapeutics companies are focused on engaging in strategic alliances to strengthen their market position. Small molecules are generally less expensive than biologics and are likely to emerge in the near future in a strong way. By offering a complete analysis of the market’s competitive landscape and with information on the products offered by the companies, this rheumatology therapeutics industry analysis report will aid clients to identify new growth opportunities and design new growth strategies.
The report offers a complete analysis of various companies including:
With a complete study of the growth opportunities for the companies, the Americas region will account for the highest growth of this market throughout the forecast period.
The biologicals segment will account for the highest market share in global rheumatology therapeutics market. Additionally, the report also provides an accurate prediction of the contribution of the various molecule types segments to the growth of the rheumatology therapeutics market size.
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: MARKET LANDSCAPE
PART 05: MARKET SIZING
PART 06: FIVE FORCES ANALYSIS
PART 07: PIPELINE LANDSCAPE
PART 08: MARKET SEGMENTATION BY MOLECULE TYPE
PART 09: REGIONAL LANDSCAPE
PART 10: CUSTOMER LANDSCAPE
PART 11: DECISION FRAMEWORK
PART 12: DRIVERS AND CHALLENGES
PART 13: MARKET TRENDS
PART 14: VENDOR LANDSCAPE
PART 15: VENDOR ANALYSIS
PART 16: APPENDIX
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.